RxDoctor Payments Data

Blair Skolnick, MD

Psychiatry · Manhasset, NYNPI 1619039310

Payments from drug & device makers

$4,294in general payments, 2019–2025

Across 182 payments — averaging $23.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$996
  • Neurocrine Biosciences, Inc.$805
  • AbbVie$712
  • Otsuka America Pharmaceutical, Inc.$423
  • Sunovion Pharmaceuticals Inc.$282
  • Lundbeck LLC$270
  • plus $806 from 9 others

What the payments were for

  • Food & beverage$4,06395%
  • Education$2315%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,294 in reported general payments places this provider in the 85th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York

Medicare billing

Part B allowed, 2024
$25,952
Medicare patients
32
Services billed
245

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine31$242,545
Austedo XrDeutetrabenazine12$86,261
Lisdexamfetamine Dimesylate16$3,987
VyvanseLisdexamfetamine Dimesylate11$3,528
Dextroamphetamine Sulfate ErDextroamphetamine Sulfate24$1,571
Bupropion XlBupropion Hcl26$700
Duloxetine Hcl63$668
Trazodone Hcl55$563
Escitalopram Oxalate37$516
Fluvoxamine Maleate15$483
Clonazepam58$429
Fluoxetine Hcl52$365
Sertraline Hcl73$311
Lamotrigine32$269
Risperidone13$232

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo, Austedo Xr$996$328,80643 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$228$3,52811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,713 psychiatry providers in New York.

Other psychiatry in Manhasset

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →